Naratriptan Neuraxpharm

Naratriptan, the active ingredient in Naratriptan Neuraxpharm, is a triptan (selective serotonin 5‑HT1B/1D receptor agonist) presented as an oral tablet for oral use. It is indicated for the acute treatment of migraine attacks in adults.

GNH USA supplies Naratriptan Neuraxpharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. With a focus on reliable logistics and comprehensive documentation, GNH USA facilitates seamless import and distribution across multiple regions.

Naratriptan belongs to the triptan class and is used to treat migraine attacks.

- Migraine (with or without aura): provides rapid relief of headache pain and associated symptoms when taken at the onset of an attack. - Acute migraine episodes: reduces the severity and duration of migraine attacks. - Migraine with aura: alleviates headache and visual disturbances when administered early.

Common Side Effects: - Dizziness: mild to moderate sensation of light‑headedness. - Nausea: transient upset stomach. - Fatigue: feeling unusually tired. - Dry mouth: reduced salivation. - Tingling sensations: paresthesia in extremities. - Flushing: temporary warmth or redness of the skin.

Serious or Rare Side Effects: - Chest pain or tightness: possible cardiac ischemia. - Severe hypertension: sudden increase in blood pressure. - Serotonin syndrome: agitation, hyperreflexia, fever. - Allergic reactions: rash, swelling, anaphylaxis. - Cardiac arrhythmias: irregular heart rhythm. - Ischemic stroke: rare cerebrovascular event.

Before using Naratriptan, consider the following precautions: - Cardiovascular assessment: evaluate history of coronary artery disease or uncontrolled hypertension. - Drug contraindications: avoid if patient has used ergotamine derivatives within 24 hours. - Serotonergic risk: monitor for signs of serotonin syndrome when combined with other serotonergic agents. - Pregnancy and lactation: use only if benefits outweigh potential risks; data are limited. - Age considerations: safety in pediatric patients has not been established. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Naratriptan may interact with several medication classes.

Major Interactions (Avoid): - MAO inhibitors: risk of severe hypertension and serotonin syndrome. - Other triptans: additive vasoconstrictive effects. - Ergot derivatives: increased vasospasm risk. - SSRIs, SNRIs, or other serotonergic drugs: potential serotonin syndrome. - Certain antihypertensives: may blunt therapeutic effect.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole): may increase naratriptan plasma levels. - Oral contraceptives: possible reduced efficacy of migraine relief. - NSAIDs: monitor for gastrointestinal irritation. - Diuretics: watch for electrolyte disturbances. - Antidepressants (non‑serotonergic): assess for additive side effects.